Blog articles

Diverse genomic study pinpoints Covid-19 variant
Sometimes data diversity can make the difference. We look at findings from a new Covid-19 study to find out how

Cancer vs the immune system
This week, we explore the ways cancer cells can evade our bodies’ defences and how we can fight back

Targeting oncogenes: a two-drug treatment
Is two better than one? We look at findings from a cancer study that explores a novel two-drug approach to treat rare ovarian cancer

Covid-19 'neanderthal' gene variants explained
In light of new research, we revisit the role our genome plays in the severity of Covid-19 symptoms

NICE approves RNAi therapy for porphyria
This week, we look at the latest gene silencing treatment approved by NICE – this time for an acute form of porphyria

Genes, hormones and blood pressure
This week, we explore genomics’ role in primary aldosteronism – a hormone disorder that leads to high blood pressure

RNAi: a new approach to combat cholesterol
The new cholesterol drug inclisiran is currently making headlines after being approved for use in the NHS, but how does it work?

Covid-19: susceptibility and the genome
An international collaboration has discovered new links between our genome and the variable onset and severity of Covid-19

Trial underway for hATTR therapy
The novel ‘one off’ treatment could change the lives of those living with the condition

Combating cancer: POLQ inhibitors
We explore a novel treatment that could help treat cancer by preventing DNA repair in tumours

Genomics in practice: ‘We are generation genome!’
In the second of our #GenomicsConversation Q&As, gynaecology cancer nurse Tracie Miles reveals how her patients inspired her to get into genomics
News articles

Funded course for nurses looking to build their genomic skills
Nurses keen to learn about genomics and counselling can apply…